Skip to main content

Krishna Institute of Medical Sciences Ltd

Stage 3 · Topping · week 5

As of 9 Oct 2026, Krishna Institute of Medical Sciences is in Stage 3 — topping, where an uptrend loses steam, in week 5 (since 9 Sep 2026). It closed at ₹706, 17.1% below its 52-week high and below its 200-day average, which is rising. In Health Care, 44.6% of stocks are in Stage 2.

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. More about the company

₹705.5
+2.67% today
₹29,631 Cr · Large cap
Market Neutral — FadingHealth Care 44.6% in Stage 2-2.6 pts / 20dHospitals & Diagnostic Centres 32.3%-6.5 pts

Pro read

Pro

Our read

Topping — the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is KIMS early, or has it already run? Pro answers that for every NSE stock, after every close.

Loading price chart…
vs 52W High
-17.1%
₹582.1 lo₹850.7 hi
17.1% below 52W high — weakening from peak
Stock is rolling over from its 52W high. Stage 3 distribution — new longs are high risk here.
Stage Maturity
Week 5
1w13w26w
Week 5 — early distribution
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
-2.2%
200 DMA: ₹721.2 · rising
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
0.83x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution — institutions are exiting. A clear warning to avoid new longs.
Trend Health
↓
MA20 rolling over · -2.2% vs MA50 -2.5%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-7.7%
3M
-13.4%
6M
+6.2%
YTD
+10.1%
1Y
+2.6%
Sector
Health Care
↓ Peaking
Stage 2%
44.6%
20d Δ
-2.6pp
1M return
-4.9%
3M return
+0.2%
Sector Stage-2 % · last 20 days
Sector has 74 Stage 2 leaders. See Health Care Stage 2 →
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
32.3%
20d Δ
-6.5pp
1M return
-8.1%
3M return
-10.8%
Industry Stage-2 % · last 20 days
Industry has 9 Stage 2 leaders. See Hospitals & Diagnostic Centres Stage 2 →
Stage Cycle Timeline2023-07-14 → 2026-10-09
S2 17w
S2 16w
S2 31w
S2 24w
S2 14w
2023-07-142026-10-09
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 17w → S3 7w → S2 16w → S3 5w → S4 5w → S1 3w → S2 31w → S3 8w → S2 24w → S3 11w → S4 9w → S1 12w → S2 14w → S3 4w current
Total tracked: 168 weeks across 14 stage runs.
Scan Membership
Breakout Watch
Latest: 2026-06-01
3 appearances in last 60 days. First seen: 2024-07-23.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-09S3
Wk 5 · Vol 0.83x
2026-10-08S3
Wk 4 · Vol 0.76x
2026-10-07S3
Wk 4 · Vol 1.13x
2026-10-06S3
Wk 4 · Vol 1.49x
2026-10-05S3
Wk 4 · Vol 1.40x
2026-10-01S3
Wk 4 · Vol 1.50x
2026-09-30S3
Wk 3 · Vol 4.19x
2026-09-29S3
Wk 3 · Vol 0.72x
2026-09-28S3
Wk 3 · Vol 0.60x
2026-09-25S3
Wk 3 · Vol 0.62x
2026-09-24S3
Wk 3 · Vol 0.47x
2026-09-23S3
Wk 2 · Vol 0.58x
Sector Peers — Stage 2All →
BAFNAPH
wk 18 · 0.0% from hi
8.6
ZIMLAB
wk 22 · 0.0% from hi
8.3
KILITCH
wk 2 · -7.3% from hi
8.3
SMSPHARMA
wk 3 · -8.0% from hi
8.3
RPGLIFE
wk 16 · -12.0% from hi
7.6
Moving averages & range
50 DMA
₹774.7
200 DMA
₹721.2
52W High
₹850.7
52W Low
₹582.1
5D Low
₹687.2
Resistance levels (recent highs)
20d High
₹809.9
60d High
₹820.6
120d High
₹850.7
250d High
₹850.7
Next resistance
+14.8%
to 20d High
P/E (TTM)
129.2
Forward 45.3
Earnings Growth (YoY)
-58.3%
Revenue +34.8%
ROE
+9.7%
Profit margin +6.2%
About this companyHealth Care· Hospitals & Diagnostic Centres

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers neurology, neurosurgery, psychiatry, and neuro rehabilitation; cardiology, cardiac and vascular surgery, heart transplant, and cardio rehabilitation; and pulmonology, interventional pulmonology, thoracic surgery, and lung transplant. It also provides medical and surgical gastroenterology, hepatobiliary pancreatic surgery, liver transplant, and bariatric surgery; ear, nose, throat, and head and neck surgery; and nephrology, urology, andrology, renal transplant, gynecology, urogynecology, IVF and art, fetal medicine, and obstetrics. In addition, the company offers orthopedics, arthroscopic and spine surgery, and ortho rehabilitation; medical surgical and radiation, and BMT and hematology; ophthalmology; dermatology, cosmetology, and plastic and reconstructive surgery; and clinical infectious diseases. Further, it provides imaging and interventional radiology; paediatrics and pediatric sub specialities, and neonatology; maxillo-facial surgery; OT and day care anaesthesia and pain medicine; and pathology, microbiology, and biochemistry. Additionally, the company offers molecular biology and clinical hematology; internal medicine, general surgery, and diabetology and endocrinology; and ICU, CTICU, SICU, NICU, PICU, neuro and ECMO ICU, and post transplant ICU services. Krishna Institute of Medical Sciences Limited was incorporated in 1973 and is based in Secunderabad, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-09. Past data patterns are not indicative of future results. This page is a data analytics tool only.